Polish version of SARC-F to assess sarcopenia in older adults: An examination of reliability and validity

被引:12
作者
Krzyminska-Siemaszko, Roma [1 ]
Deskur-Smielecka, Ewa [1 ]
Kaluzniak-Szymanowska, Aleksandra [1 ]
Styszynski, Arkadiusz [1 ]
Wieczorowska-Tobis, Katarzyna [1 ]
机构
[1] Poznan Univ Med Sci, Dept Palliat Med, Poznan, Poland
来源
PLOS ONE | 2020年 / 15卷 / 12期
关键词
QUESTIONNAIRE; VALIDATION; TRANSLATION; CONSENSUS; TOOL;
D O I
10.1371/journal.pone.0244001
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction SARC-F is a quick questionnaire recommended as a screening tool for sarcopenia. The aim of the study was to translate, adapt, and validate the Polish version of the SARC-F for community-dwelling older adults in Poland. Materials and methods We included 160 Polish volunteers aged >= 60 years (44% of men). The Polish version of SARC-F was adapted following standardized forward-backward translation procedure. SARC-F was validated against the six sets of diagnostic criteria as the reference standards [developed independently by European Working Group on Sarcopenia in Older People1 (EWGSOP1), European Working Group on Sarcopenia in Older People2 (EWGSOP2), Foundation for the National Institutes of Health (FNIH) Sarcopenia Project, Asia Working Group for Sarcopenia (AWGS), the International Working Group for Sarcopenia (IWGS), and Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD)]. Results SARC-F score >= 4 points was observed in 18.8% of the study population. Cronbach's alpha was 0.70. The sensitivity of SARC-F varied from 33.3% to 50.0% depending on the diagnostics criteria used, while the specificity was about 85%. Positive predictive value (PPV) was low (about 30%) for five out of six sets of the diagnostic criteria used (EWGSOP2, IWGS, AWGS, FNIH, and SCWD), while the negative predictive value (NPV) was generally high (>88%). The area under the ROC curves (AUC) was 0.652-0.728. SARC-F had the largest AUC against FNIH criteria (0.728), indicating a moderate diagnostic accuracy. Similar results were found for EWGSOP2 and IWGS criteria. The AUC values were below 0.7 for AWGS, SCWD, and EWGSOP1 criteria. Conclusion Based on the results, the Polish version of SARC-F shows excellent reliability and good internal consistency. High specificity and high NPV make SARC-F a useful tool to rule-out sarcopenia with high accuracy in community-dwelling older adults, independently of the diagnostic criteria used.
引用
收藏
页数:15
相关论文
共 39 条
  • [1] [Anonymous], 2018, OBSTET GYNECOL, V13, pe49
  • [2] [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40
  • [3] PERFORMANCE OF SARC-F IN REGARD TO SARCOPENIA DEFINITIONS, MUSCLE MASS AND FUNCTIONAL MEASURES
    Bahat, G.
    Yilmaz, O.
    Kilic, C.
    Oren, M. M.
    Karan, M. A.
    [J]. JOURNAL OF NUTRITION HEALTH & AGING, 2018, 22 (08) : 898 - 903
  • [4] Cross-cultural adaptation and validation of the SARC-F to assess sarcopenia: methodological report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group
    Bahat, Gulistan
    Yilmaz, Ozlem
    Oren, Meryem Merve
    Karan, Mehmet Akif
    Reginster, Jean Yves
    Bruyere, Olivier
    Beaudart, Charlotte
    [J]. EUROPEAN GERIATRIC MEDICINE, 2018, 9 (01) : 23 - 28
  • [5] Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice
    Barbosa-Silva, Thiago Gonzalez
    Baptista Menezes, Ana Maria
    Bielemann, Renata Moraes
    Malmstrom, Theodore K.
    Gonzalez, Maria Cristina
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2016, 17 (12) : 1136 - 1141
  • [6] French translation and validation of the sarcopenia screening tool SARC-F
    Beaudart, Charlotte
    Locquet, Medea
    Bornheim, Stephen
    Reginster, Jean-Yves
    Bruyere, Olivier
    [J]. EUROPEAN GERIATRIC MEDICINE, 2018, 9 (01) : 29 - 37
  • [7] Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis
    Beaudart, Charlotte
    Zaaria, Myriam
    Pasleau, Francoise
    Reginster, Jean-Yves
    Bruyere, Olivier
    [J]. PLOS ONE, 2017, 12 (01):
  • [8] Cederholm T., 2019, J CACHEXIA SARCOPENI, V38, P1, DOI [10.1016/j.clnu.2018.08.002, DOI 10.1002/jcsm.12383]
  • [9] Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
    Chen, Liang-Kung
    Liu, Li-Kuo
    Woo, Jean
    Assantachai, Prasert
    Auyeung, Tung-Wai
    Bahyah, Kamaruzzaman Shahrul
    Chou, Ming-Yueh
    Chen, Liang-Yu
    Hsu, Pi-Shan
    Krairit, Orapitchaya
    Lee, Jenny S. W.
    Lee, Wei-Ju
    Lee, Yunhwan
    Liang, Chih-Kuang
    Limpawattana, Panita
    Lin, Chu-Sheng
    Peng, Li-Ning
    Satake, Shosuke
    Suzuki, Takao
    Won, Chang Won
    Wu, Chih-Hsing
    Wu, Si-Nan
    Zhang, Teimei
    Zeng, Ping
    Akishita, Masahiro
    Arai, Hidenori
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2014, 15 (02) : 95 - 101
  • [10] Sarcopenia: revised European consensus on definition and diagnosis
    Cruz-Jentoft, Alfonso J.
    Bahat, Gulistan
    Bauer, Juergen
    Boirie, Yves
    Bruyere, Olivier
    Cederholm, Tommy
    Cooper, Cyrus
    Landi, Francesco
    Rolland, Yves
    Sayer, Avan Aihie
    Schneider, Stephane M.
    Sieber, Cornel C.
    Topinkova, Eva
    Vandewoude, Maurits
    Visser, Marjolein
    Zamboni, Mauro
    [J]. AGE AND AGEING, 2019, 48 (01) : 16 - 31